BAC Overview

  • Founded
  • 1995
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 5

BAC General Information

Description

Provider of affinity purification products and services for the biopharmaceutical market. The company develops affinity ligands and affinity purification products for the biopharmaceutical research and production market. The company also offers affinity separation products for the discovery, preclinical and clinical manufacturing of therapeutic proteins, antibodies and antibody fragments, vaccines and viruses.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Huizerstraatweg 28
  • 1411 GP Naarden
  • Netherlands
+31 035 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BAC Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BAC‘s full profile, request access.

Request a free trial

BAC Executive Team (2)

Name Title Board Seat Contact Info
Laurens Sierkstra Ph.D Chief Executive Officer
Andrew Lane Director
To view BAC’s complete executive team members history, request access »

BAC Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BAC‘s full profile, request access.

Request a free trial